Italian biotech MimeTech has announced that the European Medicines Agency (EMA) has granted PRIority MEdicines (PRIME) ...

Kim Assender, the Association of the British Pharmaceutical Industries’ (ABPI) director of commercial policy and analysis, ...

US pharma giant Merck & Co, known as MSD outside of the USA and Canada, today announced that the European Commission (EC) has ...

Swiss biopharma Relief Therapeutics today announced positive results from its pivotal bioequivalence clinical study ...

Shares in UK pharma major GSK were 6% higher late Wednesday after the London-based drugmaker presented its third quarter ...

Shares in Swiss pharma giant Novartis closed 4% lower Tuesday after the firm reported its third-quarter 2025 financial ...

South Korean biosimilar specialist Samsung Bioepis revealed it has entered into an asset purchase agreement (APA) with Biogen ...

US clinical stage biotech Armata Pharmaceuticals’ investigational phage therapy, AP-SA02, demonstrated earlier resolution in ...

Australian biotech Myrio Therapeutics has joined forces with the University of Pennsylvania’s Perelman School of Medicine and ...

The European Medicines Agency (EMA) and its Committee for Medicinal Products for Human Use (CHMP) set the pace in Europe, ...

Roche (ROG: SIX) has reported positive top-line results from the Phase III INShore study of Gazyva (obinutuzumab) in children ...

China-headquartered Innovent Bio has announced that the fourth Phase III trial DREAMS-3 of mazdutide, a glucagon-like peptide ...